SNC Therapeutics, Inc.

Biotechnology company · Evanston, Illinois, United States

SNC Therapeutics, Inc. is a biotechnology company headquartered in Evanston, Illinois, United States. Its earliest recorded incorporation is in 2022. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $350,000 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $249,999 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

SNC Therapeutics at a glance

Typebiotechnology company
HeadquartersEvanston, Illinois, United States
Earliest incorporation on record2022
Employees (self-reported, 2025)2
SEC CIK1966964

What does SNC Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $350,000 in total (2025). NIH funding came from the National Institute of Diabetes and Digestive and Kidney Diseases.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $249,999 sold (2023).

Frequently asked questions about SNC Therapeutics

Where is SNC Therapeutics headquartered?

SNC Therapeutics, Inc. is headquartered in Evanston, Illinois, United States.

What does SNC Therapeutics do?

SNC Therapeutics, Inc. is a biotechnology company.

When was SNC Therapeutics founded?

The earliest incorporation on record for SNC Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences